Alnylam Pharmaceuticals (ALNY) PT Raised to $242 at Morgan Stanley

October 12, 2021 2:41 AM EDT
Get Alerts ALNY Hot Sheet
Price: $198.61 -2.8%

Rating Summary:
    19 Buy, 12 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 18 | New: 32
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $242.00 (from $234.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change